TABLE 3.
Groups |
Subgroup A (1 mo) |
Subgroup B (2 mo) |
Subgroup C (3 mo) |
P‐value | |||
---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | ||
Group I (blood clot) |
0.37aA (6.5%) |
0.02 |
0.50bA (9.1%) |
0.07 |
0.82cA (27.8%) |
0.11 | ≤.001* |
Group II (EDTA + blood clot) |
0.39aAB (7.1%) |
0.03 |
0.57bA (10.4%) |
0.10 |
0.91cB (29.1%) |
0.09 | ≤.001* |
Group III (PRF) |
0.40aAB (8%) |
0.06 |
0.68bB (14.1%) |
0.08 |
0.98cB (35.1%) |
0.11 | ≤.001* |
Group IV (EDTA + PRF) |
0.42aB (8.1%) |
0.05 |
0.72bB (14.9%) |
0.12 |
1.20cC (36.3%) |
0.10 | ≤.001* |
Group V (positive control) |
0.00 | 0.00 | 0.00 | ||||
Group VI (negative control) |
0.83aC (13.2%) |
0.09 |
1.20bC (22.1%) |
0.11 |
1.40cD (38.2%) |
0.05 | ≤.001* |
P‐value | ≤0.001* | ≤0.001* | ≤0.001* |
The same upper‐case letters within each column indicate differences that were not significant.
The same lower‐case letters within each row indicate differences that were not significant.
Abbreviation: NS, not significant.
Significant at P ≤ .05.